A Review of the Ingredients Contained in Over the Counter OTC Cough Syrup Formulations in Kenya. Are They Harmful to InfantsReport as inadecuate




A Review of the Ingredients Contained in Over the Counter OTC Cough Syrup Formulations in Kenya. Are They Harmful to Infants - Download this document for free, or read online. Document in PDF available to download.

Background

Cough syrups are widely used in the developing world, but safety of their use in infants and children less than two years has not been well documented. Some syrups contain multiple combinations of such drugs as promethazine, diphenhydramine and ephedrine; which are individually now contraindicated in children less than two years. Despite this, the syrups are available as over the counter drugs and may be dispensed to mothers who are unaware of the potentially hazardous effects to their infants. A descriptive cross-sectional study was used to investigate suitability of cough syrups sold within Eldoret municipality for use in children less than two years of age based on their formulations and available literature.

Methods

Two semi-structured questionnaires were administered to pharmacy attendants and mothers attending sick child clinic at a referral hospital to establish whether cough syrups containing more than one active ingredient of compounds, now contraindicated in children are administered to infants, and awareness of potential serious adverse effects. Data from labeled contents of cough syrups from retail pharmacies was recorded and corroborated with information from literature to determine those deemed to contain the ingredients. The second questionnaire was administered to mothers with children less than two years to ascertain whether they had used the identified syrups. A total of 260 mothers and 55 pharmacy attendants were interviewed.

Results

There was widespread use of the syrups in children, including infants, with 192 74% of the respondents having used identified syrups and over 90% of these on children less than 2 years including those less than three months.146 76% mothers had administered the syrup at double the recommended dose.

Conclusion

The regulatory authorities should make concerted efforts to discourage use of cough syrups containing ingredients that pose adverse events to infants, including campaigns to educate pharmacy workers and mothers.



Author: Gabriel Kigen , Naftali Busakhala , Francis Ogaro , Emily Chesire , Nathan Saat , Robert Too , Winstone Nyandiko

Source: http://plos.srce.hr/



DOWNLOAD PDF




Related documents